NCT01396525View on ClinicalTrials.gov

Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery

PHASE3CompletedINTERVENTIONAL

Enrollment

153

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

September 30, 2011

Study Completion Date

June 30, 2014

Conditions

Peripheral Vascular Disease

Interventions

DEVICE

Omnilink Elite™ Peripheral Balloon-Expandable Stent System

Patients with treatment of a maximum of two bilateral de novo or restenotic atherosclerotic lesions in the native common iliac artery and/or native external iliac artery (one lesion per side).

Trial Locations (1)

95054

Abbott Vascular, Santa Clara